GASTROESOPHAGEAL ADENOCARCINOMA
Clinical trials for GASTROESOPHAGEAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced stomach cancer? phase 3 trial tests zanidatamab combo
Disease control OngoingThis study tests whether a new drug called zanidatamab, given with chemotherapy and sometimes another drug (tislelizumab), works better than the current standard treatment for advanced HER2-positive stomach and esophageal cancer. About 920 adults whose cancer has spread or cannot…
Matched conditions: GASTROESOPHAGEAL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 10:35 UTC
-
New hope for advanced cancers: experimental drug ABBV-400 enters human trials
Disease control OngoingThis early-stage study tests an investigational drug called ABBV-400, alone or with another drug (bevacizumab), in about 520 adults with advanced solid tumors including lung, stomach, and colorectal cancers. The goal is to find the safest and most effective dose and see if it can…
Matched conditions: GASTROESOPHAGEAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated May 26, 2026 10:30 UTC